Aclarion Inc. has established a commercial agreement with Scripps Health in San Diego, Calif., expanding access to its Nociscan technology for spine physicians and more than 3.2 million residents in the greater San Diego area.
The Nociscan technology utilizes MR Spectroscopy (MRS) and Augmented Intelligence to identify sources of chronic low back pain. Scripps Health is the largest healthcare system in the San Diego area, comprising five hospitals and 19 outpatient facilities.
“Each year at Scripps, we evaluate a large, growing number of patients suffering from chronic low back pain,” said Dr. Robert Eastlack, orthopedic surgeon, Scripps Health. “I have a keen interest in advanced diagnostics and clinical decision support tools like Nociscan. Over the last few years, I have referred numerous patients to Beverly Hills for Nociscan. The additional information unique from Nociscan has been valuable to me and my patients. Having Nociscan available at Scripps Green will greatly expand access to my colleagues and our patients in important ways.”
Ryan Bond, chief strategy officer of Broomfield-based Aclarion, noted Dr. Eastlack’s leadership within Scripps and his extensive contributions to the field. “We are pleased to bring Nociscan to Scripps Health and the millions of people throughout Southern California,” Bond said. “Dr. Eastlack and his colleagues will now be able to utilize Nociscan in clinic and within ongoing research trials, both of which are vitally important to their mission of advancing spine care.”
According to Aclarion, chronic low back pain is a significant global healthcare issue, affecting approximately 266 million people worldwide. The Nociscan solution is the first evidence-supported SaaS platform designed to assist physicians in distinguishing between painful and nonpainful discs in the lumbar spine, providing insights for better patient care.
